Data & Analytics

Nomic and the Wellcome Sanger Institute unite to profile immune diversity in underrepresented populations, using proteomics to bridge the gap from gene to function.

A new transatlantic force in financial services M&A is born as UK's Fenchurch merges with US fintech specialist Broadhaven, creating a 110-banker powerhouse.

GovSpend's new MCP Server isn't just a feature. It's a look at the future of enterprise data, where direct AI integration becomes the ultimate competitive edge.

The PD-L1 biomarker testing market is set to double by 2036, fueling a revolution in cancer care. But as innovation races ahead, who gets left behind?

Lead Edge Capital’s investment in Elektrik isn't just another tech deal. It’s a bet on the unglamorous but critical hardware supply chain fueling the AI era.

A new program in Nevada is using breath-based tech to tackle first responder burnout. But can a simple device truly change the complex health of those who serve?

An award for Fivetran and Databricks reveals the real story in AI: success isn't about models, but the profitable data foundations they're building.

As banks shift from AI experiments to high-stakes deployment, a key hire signals a new era for financial intelligence and a major strategic play by Arizent.

Komodo Health restructures its C-suite, signaling a major shift in healthcare. It's no longer about AI hype; it's about enterprise-scale dominance.

In a strategic pivot, GeneDx brings in former Quest and Thermo Fisher exec Mark Gardner to translate its genomic leadership into commercial dominance.

Millions of adults are straightening their teeth, but not with braces. We examine the tech, economics, and human behavior driving the clear aligner boom.

A new corporate alliance is targeting veteran lung disease. It’s more than a webinar; it’s a strategic response to the PACT Act’s seismic shift.

An executive's award reveals a deeper truth: the auto industry's future isn't about cars, but the complex data ecosystems that run them. A look inside Authenticom.

Entrada's recent award from Databricks isn't just a trophy; it's a signal that the hardest part of enterprise AI—governed context—is now solvable.

Arima Genomics' award-winning Aventa test is revolutionizing lymphoma diagnostics by seeing cancer in 3D, moving beyond 2D methods to find what others miss.

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

As military power goes digital, a new arms race is on for secure data centers. VisionWave's high-stakes plan for a hardened Israeli facility reveals the future.

As employees adopt unapproved AI tools, businesses face a 'shadow AI' crisis. We explore how integrating intelligence directly into workflows is the key to ROI.

Pharma giant MSD and health-tech innovator Nivi are using an AI chatbot to fight cervical cancer in Asia. Can this model overcome regulatory hurdles and scale?

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.